Overall rank by patents
#16,211
Across all tracked assignees
USPTO PatentsView assignee record - 18 granted patents across 18 technology areas, active 2017–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: D04B (KNITTING).
The verdict
Myant holds 18 US patents across 18 technology areas, rank #16,211 of 50,000 tracked assignees.
Myant Inc. has been granted 18 US utility patents between 2017 and 2025, placing Myant Inc. at rank #16,211 across all assignees tracked by PlainPatent. This portfolio spans 18 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.3 claims per patent with primary concentration in D04B (KNITTING). As a Foreign Corporation, Myant Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Myant sits between Momentis Surgical Ltd (18 patents, rank #16,207) and Neatfreak Group Inc. (18 patents, rank #16,215) - the closest US assignees by grant volume. The composite Innovation Score of 41.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 17 grants, compared with 1 in the 2015–2019 window, a +1600% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Myant Inc.'s 14.3 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 18 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Myant Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Momentis Surgical Ltd
18 patents
Montana Systems Inc.
18 patents
Morris & Associates, Inc.
18 patents
Motiv NV
18 patents
NACHI-FUJIKOSHI CORP.
18 patents
NATIONAL INSTITUTES FOR QUANTUM SCIENCE AND TECHNOLOGY
18 patents
NATIONAL SYNCHROTRON RADIATION RESEARCH CENTER
18 patents
NEATFREAK GROUP INC.
18 patents
Myant Inc.
18 patents
What this shows Myant holds 18 patents at rank #16,211, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #16,211 in granted patent volume.
Other assignees with the most granted patents in Myant's primary technology class.
Myant's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
42 Top 32% higher than 68% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 1 | 5.6% |
| 2020 | 1 | 5.6% |
| 2021 | 4 | 22.2% |
| 2022 | 1 | 5.6% |
| 2024 | 5 | 27.8% |
| 2025 | 6 | 33.3% |
Top 15 of 18 technology areas
Overall rank by patents
#16,211
Across all tracked assignees
41.7 out of 100
How to use this portfolio
Myant's 18 grants land it in the top 32% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.